Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tien M H Ng

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Pharmacotherapy|January 5, 2005
Levosimendan, a new calcium-sensitizing inotrope for heart failureTien M H Ng
Journal of Cardiac Failure|September 9, 2015
Natriuretic Peptides as Therapy for Heart Failure--Unfulfilled Promise?Tien M H Ng
JACC. Advances|June 28, 2024
Clinical Decision Support Tools for Optimizing Guideline-Directed Medical Therapy for Heart Failure: Computing the PossibilitiesTien M H Ng
Journal of Pharmacy Practice|April 22, 2011
Introduction: infectious diseases in the critically illKeith M Olsen, Tien M H Ng
The Annals of Pharmacotherapy|April 24, 2003
Effects of subclinical hypothyroidism and its treatment on serum lipidsBeata A Ineck, Tien M H Ng
Journal of Cardiac Failure|August 4, 2019
Is There an Optimal Time or Method to Obtain BNP Levels?Tien M H Ng, Samantha L Yeung
Cardiology in Review|September 3, 2015
Relaxin for the Treatment of Acute Decompensated Heart Failure: Pharmacology, Mechanisms of Action, and Clinical EvidenceTien M H Ng, Sorel Goland, Uri Elkayam
JAMA Cardiology|March 2, 2017
Reconfiguring the Hospital-to-Home Transition Into an Active Treatment Period for Patients With Heart FailureTien M H Ng, Rishi Menon, Paul J Hauptman
Pharmacotherapy|June 2, 2005
Moxifloxacin and warfarin: additional evidence for a clinically relevant interactionLindsay M Arnold, Lindsay R Nissen, Tien M H Ng
Journal of Cardiovascular Pharmacology and Therapeutics|June 3, 2015
Direct Vasodilators and Sympatholytic AgentsMeghan N McComb, James Y Chao, Tien M H Ng
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Pharmacotherapy|January 5, 2005
Levosimendan, a new calcium-sensitizing inotrope for heart failureTien M H Ng
Journal of Cardiac Failure|September 9, 2015
Natriuretic Peptides as Therapy for Heart Failure--Unfulfilled Promise?Tien M H Ng
JACC. Advances|June 28, 2024
Clinical Decision Support Tools for Optimizing Guideline-Directed Medical Therapy for Heart Failure: Computing the PossibilitiesTien M H Ng
Journal of Pharmacy Practice|April 22, 2011
Introduction: infectious diseases in the critically illKeith M Olsen, Tien M H Ng
The Annals of Pharmacotherapy|April 24, 2003
Effects of subclinical hypothyroidism and its treatment on serum lipidsBeata A Ineck, Tien M H Ng
Journal of Cardiac Failure|August 4, 2019
Is There an Optimal Time or Method to Obtain BNP Levels?Tien M H Ng, Samantha L Yeung
Cardiology in Review|September 3, 2015
Relaxin for the Treatment of Acute Decompensated Heart Failure: Pharmacology, Mechanisms of Action, and Clinical EvidenceTien M H Ng, Sorel Goland, Uri Elkayam
JAMA Cardiology|March 2, 2017
Reconfiguring the Hospital-to-Home Transition Into an Active Treatment Period for Patients With Heart FailureTien M H Ng, Rishi Menon, Paul J Hauptman
Pharmacotherapy|June 2, 2005
Moxifloxacin and warfarin: additional evidence for a clinically relevant interactionLindsay M Arnold, Lindsay R Nissen, Tien M H Ng
Journal of Cardiovascular Pharmacology and Therapeutics|June 3, 2015
Direct Vasodilators and Sympatholytic AgentsMeghan N McComb, James Y Chao, Tien M H Ng
Pageof 4